Sign in
Taking people in United StatesNo phase

Studies heart and blood vessel disease in people with rare conditions

Studies heart and blood vessel changes in people with metabolic, inflammatory or genetic diseases.

Key facts

Who runs it
National Heart, Lung, and Blood Institute (NHLBI)
Where
Bethesda and Washington D.C., United StatesSee the 3 sites
Trial code
Registry title
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Status
Recruiting
People taking part
5,000 people, planned
Started
21 Jul 2010
Type of study
Observational, 3 groups
Treatments tested
  • NSR IDE-MRI: Research pulse sequences
Record updated
4 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 1 to 100 with known or suspected heart or blood vessel risk from a metabolic, inflammatory or genetic condition. Relatives and healthy volunteers can also join.

Age
1 to 100 years. Healthy adult volunteers must be 18 or older.
Sex
All sexes can join.
Disease stage
People referred with a known or suspected condition that may affect the heart or blood vessels, such as an unusual presentation, an inherited disorder or a genetic risk.
Biomarker or test result
Relatives can be genetic carriers or non-carriers of the condition.

Main reasons for not taking part

  • Younger than 1 year or older than 100 years
  • Pregnant women
  • Healthy volunteers who cannot give consent or decline blood or tissue studies or storage of samples
  • People not fluent in English cannot do the questionnaires

The registry criteria, word for word

Show all 7 criteriaShow less

Who cannot take part

  • Persons of less than 1 year of age or greater than 100 years of age
  • Healthy volunteers unable to give informed consent or who decline to have blood and/or tissue studies, or who do not consent to have samples stored for future research may be excluded from this study
  • Pregnant women
  • Persons who are not fluent in the English language will be excluded from Patient Reported Outcome Questionnaires. Such persons would be unable to properly complete questionnaires that are only valid in the English language

Other criteria

  • INCLUSION CRITERIA:; Eligible subjects may include anyone over 1 year of age who is affected with diseases/disorders (index cases), or who is a relative of a person who is affected with diseases/disorders. Relatives may include genetic carriers and non-carriers
  • Healthy adult volunteers must be 18 years of age or older, and must agree to have blood or tissue samples studied, and potentially stored for future research
  • Index cases enrolled in this protocol will have been referred with a known or suspected pathology that may be associated with cardiovascular dysfunction or risk with a suspected atypical presentation, heritable disorder, or genetic predisposition. The investigator with expertise in the presentation of the subject, along with consulting specialists, will review the medical history and may review any medical records that are available of prospective subjects and offer admission based upon the potential to help the individual, to learn from the subject, or to initiate clinical or basic research suggested by the subject s workup

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 1 and 100 years old?

Where in United States

  • National Institutes of Health Clinical CenterBethesda, United StatesContact: Rebecca D Huffstutler, C.R.N.P.Taking people
  • Suburban HospitalBethesda, United StatesContact: Rebecca D Huffstutler, C.R.N.P.No longer taking part
  • Hope CenterWashington D.C., United StatesContact: Rebecca D Huffstutler, C.R.N.P.Taking people

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels. Depending on the condition being studied, both affected and nonaffected individuals may be asked to provide blood and other samples and may undergo tests to evaluate the heart, blood vessels and lung function. The testing is tailored to the individual and/or condition being studied. Nonaffected individuals may include relatives of affected individuals and healthy nonrelated volunteers.

Objectives:

- To study individuals who have or are at risk for cardiovascular diseases, and in some cases their unaffected relatives and healthy volunteers.

Eligibility:

- Individuals between 1 and 100 years of age. Participants may be healthy volunteers, individuals with cardiovascular diseases, or unaffected relatives of individuals with cardiovascular diseases.

Design:

* Participants will have some or all of the following tests, as directed by the study researchers: * Photography of the face and full body * Body measurements * Radiography, including chest or limb x-rays * Metabolic stress testing to study heart and muscle function * Echocardiography to study heart function * Magnetic resonance imaging (MRI) studies, including cardiovascular MRI, angiography, and contrast MRI, to study heart function and performance * Computed tomography (CT) angiogram to obtain images of the heart and lungs * Positron emission tomography (PET) imaging to study possible fat infiltration of the heart * Six-minute walk test to study heart, lung, and muscle function and performance * Vascular ultrasound to study blood vessel walls * Blood, tissue, and other specimens will be collected for research and testing, and will be taken either as part of the clinical study or during surgical procedures. * Follow-up studies may be performed under separate research protocols.

The 3 groups in the trial

  • 1. Adult index cases and relatives

    Enrolled with a known or suspected pathology that may be associated w/cardiovascular dysfunction or risk w/suspected atypical presentation, heritable disorder, or genetic predisposition.

    Treatment: NSR IDE-MRI: Research pulse sequences

  • 2. Child index case and child relatives

    Children over 1 year of age who is affected with diseases/disorders (index cases), or who is a relative of a person who is affected with diseases/disorders.

    Treatment: NSR IDE-MRI: Research pulse sequences

  • 3. Healthy adult volunteers

    Healthy adult volunteers must be 18 years of age or older, and must agree to have blood or tissue samples studied, and potentially stored for future research.

Results explained

A paper that names this trial, explained in plain words.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Cardiovascular Disease Discovery Protocol
Plain-language title
Studies heart and blood vessel disease in people with rare conditionsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT01143454, who can take part
Publications
Record updated
4 November 2026